Discontinued — last reported Q4 '25
Finance Lease Interest
Vertex Pharmaceuticals Finance Lease Interest remained flat by 0.0% to $1.43M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 77.4%, from $6.30M to $1.43M. Over 2 years (FY 2023 to FY 2025), Finance Lease Interest shows a downward trend with a -61.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase suggests higher reliance on debt-like lease financing, while a decrease indicates reduced interest burdens from these obligations.
Detailed definition
This represents the interest portion of payments made on finance lease obligations. It reflects the cost of financing as...
Peer comparison
Commonly reported by capital-intensive firms under ASC 842 lease accounting standards.
wmt_interest_expense_finance_leasesHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $38.80M | $25.20M | $5.70M |
| YoY Change | — | -35.1% | -77.4% |
Finance Lease Interest at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's finance lease interest?
- Vertex Pharmaceuticals (VRTX) reported finance lease interest of $1.43M in Q4 2025.
- How has Vertex Pharmaceuticals's finance lease interest changed year-over-year?
- Vertex Pharmaceuticals's finance lease interest decreased by 77.4% year-over-year, from $6.30M to $1.43M.
- What is the long-term trend for Vertex Pharmaceuticals's finance lease interest?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's finance lease interest has grown at a -61.7% compound annual growth rate (CAGR), from $38.80M to $5.70M.
- What does finance lease interest mean?
- The interest cost associated with finance lease liabilities.